An enzyme with enhanced D-amino acid oxidase and its application in the synthesis of succinylphosphonate.

By mutating the gene of D-amino acid oxidase, its enzyme activity was increased, solving the problem of insufficient enzyme activity in the biocatalytic method, realizing the efficient preparation of high-purity L-glufosinate, and reducing production costs.

CN123107946APending Publication Date: 2026-11-17YIXING INST OF FOOD & BIOTECHNOLOGY CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611430137.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-15
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing chemical methods for preparing glufosinate are costly and environmentally burdensome, while the D-amino acid oxidase activity in biocatalytic methods is insufficient, making it difficult to meet the demand for efficient production of optically pure glufosinate.

Method used

By mutating the D-amino acid oxidase gene from Rhizopus cylindrica, especially by mutating glutamine at position 335 to glycine, a D-amino acid oxidase mutant Q335G with increased enzyme activity was obtained. Recombinant plasmids and recombinant cells were then constructed for catalyzing the resolution of D,L-glufosinate.

Benefits of technology

The activity of D-amino acid oxidase was improved, enabling efficient catalysis of the separation of D,L-glufosinate to produce high-purity L-glufosinate, reducing production costs and making it suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123107946A_ABST
    Figure CN123107946A_ABST
Patent Text Reader

Abstract

This invention discloses a D-amino acid oxidase with enhanced enzyme activity and its application in the synthesis of chlorpyrifos, belonging to the field of enzyme engineering. This invention provides a D-amino acid oxidase mutant, Daao, with enhanced enzyme activity. Q335G It can make the mutant Daao Q335G The enzyme activity is increased to 1.2 times that of the wild-type enzyme at the optimal temperature of 30℃ and optimal pH of 8.0, which helps to broaden its application range in the pharmaceutical field. This invention directly obtains high-purity, highly chiral excess L-glufosinate from racemic D,L-glufosinate through a two-step enzymatic reaction. Compared with traditional chemical synthesis processes, the reaction conditions are milder, and the product purity and chiral purity are higher, which greatly reduces the production cost of L-glufosinate and has good prospects for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a D-amino acid oxidase with enhanced enzyme activity and its application in the synthesis of chlorpyrifos, belonging to the field of enzyme engineering. Background Technology

[0002] Glufosinate (PPT), a phosphorus-containing, non-protein-derived amino acid, is a broad-spectrum, highly effective, and non-selective herbicide. The main active ingredient in commercially available glufosinate products is a racemic mixture of D,L-glufosinate (D,L-PPT), of which only the L-enantiomer (glufosinate-ammonium) possesses herbicidal activity. The remaining 50% of D-glufosinate not only lacks herbicidal activity but also struggles to degrade naturally.

[0003] Currently, in chemical methods, the preparation of glufosinate mainly involves asymmetric synthesis using chiral substrates or racemic reactions using racemic glufosinate as a substrate. However, the application of racemic glufosinate has led to problems such as high costs and increased environmental burden. Therefore, the development of efficient methods for producing optically pure glufosinate has attracted widespread attention. Among these methods, biocatalytic production of glufosinate, in addition to possessing the key advantage of high optical purity, also features mild reaction conditions and high conversion rates, making it the mainstream strategy for the industrial production of L-glufosinate. The biocatalytic method utilizes a fungicide derived from *Rhodotorula glutinis* (…). Rhodosporidium toruloides D-amino acid oxidase (EC: 1.4.3.3) catalyzes the oxidation of D-glufosinate to the intermediate 2-oxo-4-[(hydroxy)(-methyl)phosphono]butyric acid (PPO), which is then reductively aminationed to L-glufosinate (glufosinate-ammonium).

[0004] Furthermore, the continued growth in demand for glufosinate-ammonia has placed higher demands on the biological racemic reaction of glufosinate-ammonia. Therefore, screening for D-amino acid oxidases with higher enzyme activity is of great application value for the production of glufosinate-ammonia. Summary of the Invention

[0005] This invention provides a D-amino acid oxidase mutant derived from Rhodotorula buergerianum, wherein the D-amino acid oxidase mutant is based on the D-amino acid oxidase shown in SEQ ID NO.1, with glutamine at position 335 mutated to glycine.

[0006] In one embodiment, the D-amino acid oxidase mutant is obtained by mutating glutamine at position 335 to glycine based on the D-amino acid oxidase shown in SEQ ID NO.1, to obtain the D-amino acid oxidase mutant Q335G having the amino acid sequence shown in SEQ ID NO.2.

[0007] The present invention also provides a gene encoding the D-amino acid oxidase mutant.

[0008] In one embodiment, the gene encoding the D-amino acid oxidase mutant has a nucleotide sequence as shown in SEQ ID NO.3.

[0009] The present invention also provides a recombinant plasmid carrying the said gene.

[0010] In one embodiment, the recombinant plasmid uses the pET series as a vector.

[0011] In one embodiment, the pET series includes pET-28a.

[0012] The present invention also provides a D-amino acid oxidase mutant expressing the D-amino acid oxidase, or a recombinant cell carrying the gene or containing the recombinant plasmid.

[0013] In one embodiment, the recombinant cells are bacteria or fungi as host cells; In one embodiment, the bacteria are selected from Escherichia coli, Bacillus subtilis, or Corynebacterium glutamicum, and the fungus is yeast.

[0014] Preferably, Escherichia coli is used as the host cell.

[0015] In one embodiment, the Escherichia coli includes, but is not limited to, Escherichia coli BL21 (DE3).

[0016] The present invention also provides a recombinant enzyme catalyst containing the D-amino acid oxidase mutant, which is any one of the following forms: (1) Culture the recombinant cells and isolate cells containing the mutant; (2) Culture the recombinant cells, separate and break the cells to obtain a cell lysate containing the mutant; (3) The freeze-dried enzyme powder obtained by freeze-drying the cell lysate.

[0017] The present invention also provides a method for improving the activity of D-amino acid oxidase, wherein the method is based on the D-amino acid oxidase shown in SEQ ID NO.1, by mutating glutamine at position 335 to glycine.

[0018] The present invention also provides a genetically engineered bacterium that expresses the D-amino acid oxidase mutant.

[0019] In one embodiment, the genetically engineered bacteria also express at least one coenzyme associated with the generation of PPO.

[0020] In one embodiment, the coenzyme includes catalase.

[0021] The present invention also provides a method for resolving racemic D,L-glufosinate, wherein the method uses D,L-glufosinate as a substrate and the recombinant cells, the recombinase catalyst, or the genetically engineered bacteria as a catalyst to resolve racemic D,L-glufosinate and generate intermediate PPO.

[0022] In one embodiment, the catalytic system further includes catalase; the catalase can be any enzyme known in the art that has catalase activity.

[0023] In one embodiment, the catalytic temperature is 25-40°C and the pH is 7-8.

[0024] The present invention also provides the application of the D-amino acid oxidase mutant, or the gene or recombinant vector, or the recombinant cell, or the recombinase catalyst, or the genetically engineered bacteria, or the method in any of the following: (1) Preparation of L-glufosinate; (2) Preparation of intermediate PPO.

[0025] [Beneficial Effects] This invention provides a D-amino acid oxidase mutant Q335G with enhanced enzyme activity. Its enzyme activity after transformation at 30°C, pH 8.0, and 3 hours is 1.2 times that of the wild-type enzyme. Therefore, the D-amino acid oxidase mutant Q335G provided by this invention significantly improves enzyme activity while retaining the optimal reaction temperature and pH of the wild-type enzyme, effectively broadening its application scope in the pharmaceutical field.

[0026] The D-amino acid oxidase mutant Q335G provided by this invention can still maintain high catalytic activity in a fed-batch reaction system with a cumulative substrate concentration of up to about 120 g / L (about 662 mM), successfully achieving the accumulation of PPO intermediates and subsequent L-PPT conversion, thus overcoming the strong substrate inhibition effect of high substrate concentration on enzymes.

[0027] This invention directly yields 115.5 g / L L-glufosinate from racemic D,L-glufosinate using a two-step enzymatic method, with a conversion rate of 92.5% and ee>99%. Compared to traditional chemical synthesis processes, the reaction conditions are milder, and the product purity and chiral purity are higher, significantly reducing the production cost of L-glufosinate and demonstrating promising prospects for industrial production. Attached Figure Description

[0028] Figure 1 D-amino acid oxidase SDS-PAGE verification image; Lane 1 is the intracellular supernatant of BL21(DE3) / pET-28a-Daao; Figure 2 Relative enzyme activity of D-amino acid oxidase at different pH and temperature; Figure 3 Relative enzymatic activities of different D-amino acid oxidase mutants; Figure 4 Results of D-glufosinate conversion in a 5 L bioreactor; Figure 5 Results of L-glufosinate conversion in a 5 L bioreactor. Detailed Implementation

[0029] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention.

[0030] The following examples involve Escherichia coli (E. coli) Escherichia coli JM109 and Escherichia coli ( Escherichia coli BL21 (DE3) were all purchased from Sangon Biotech (Shanghai) Co., Ltd.; the pET-28a plasmid involved in the following examples was purchased from BioVector China Plasmid Vector Strains Cell Gene Depository Center.

[0031] In the following examples, the fermentation broth was centrifuged to collect the cells, and then resuspended in phosphate buffer to a predetermined OD value. 600 (e.g., OD) 600 =40), which serves as the source of crude enzyme solution.

[0032] The materials involved in the following embodiments are as follows: 1. Culture medium and buffer solution (1) LB liquid medium: peptone 10 g / L, yeast extract 5 g / L, NaCl 10 g / L.

[0033] (2) LB solid medium: peptone 10 g / L, yeast extract 5 g / L, NaCl 10 g / L, agar 15 g / L.

[0034] (3) TY fermentation medium: yeast extract 8 g / L, peptone 12 g / L, K3PO4 4.02 g / L, NaCl 3 g / L, citric acid monohydrate 2.1 g / L, ferric ammonium citrate 0.3 g / L, (NH4)2SO4 2.5 g / L, MgSO4·7H2O 0.5 g / L, pH 7.2.

[0035] (4) Feeding medium: 400 g / L glycerol, 50 g / L yeast extract, 25 g / L peptone.

[0036] (5) 3× phosphate buffer: NaCl 8.0 g / L, KCl 0.2 g / L, Na2HPO4 1.15 g / L, KH2PO4 0.2 g / L.

[0037] The detection methods involved in the following embodiments are as follows: (1) The enantiomers of D-PPT and L-PPT were detected by HPLC using a fluorescence detector (FLD). 1 mL of the conversion sample was boiled for 5 min, then centrifuged at 12,000 rpm for 5 min to collect the supernatant. The sample was mixed with derivatization reagent (phthalaldehyde: N-acetylcysteine ​​= 10 mg: 12 mg, first dissolved in 1 mL of anhydrous ethanol, then diluted to 5 mL with 0.1 M sodium borate buffer at pH 9.8), reacted at 30 °C for 5 min, and then filtered through a 0.22 μm filter for HPLC detection.

[0038] HPLC method: The chromatographic column was a Dima Diamonsil C18(2), 4.6 mm × 250 mm, 5 μm. The mobile phase was 0.05 M ammonium acetate (pH=5.7): methanol = 9:1, the flow rate was 1 mL / min, the column temperature was 35℃, the emission wavelength was 350 nm, and the absorption wavelength was 450 nm.

[0039] (2) PPO was detected by HPLC with a UV detector (VWD). 10 μL of 6 M HCl was added to 1 mL of the conversion sample and mixed thoroughly. The mixture was centrifuged at 12,000 rpm for 5 min and the supernatant was collected and filtered through a 0.22 μm filter membrane for HPLC detection.

[0040] HPLC method: The chromatographic column was a Dima Diamonsil C18(2), 4.6 mm × 250 mm, 5 μm. The mobile phase was 0.05 mM ammonium dihydrogen phosphate (pH=3.8):acetonitrile = 88:12, with 0.1% w / v tetrabutylammonium bromide added. The flow rate was 1 mL / min, the column temperature was 40℃, and the detection wavelength was 232 nm.

[0041] (3) Determination of glutamate dehydrogenase activity Glutamate dehydrogenase (GluDH) activity was determined by ultraviolet spectrophotometry. The total reaction volume was 1.5 mL, including 50 mM PPO, 50 mM NADPH, 50 mM PBS buffer (pH 7.5), 50 mM ammonium sulfate, and 20 μL of the enzyme solution. After reacting in a 30°C shaking water bath for 1 min, the absorbance was measured and recorded at 340 nm. Enzyme activity was calculated based on the linear rate of change of absorbance at 340 nm over time.

[0042] Enzyme activity is defined as the amount of enzyme required for glutamate dehydrogenase (GluDH) to catalyze the production of 1 μmol NADP+ per minute, which is 1 U.

[0043] (4) Determination of glucose dehydrogenase activity Glucose dehydrogenase (GDH) activity was determined by ultraviolet spectrophotometry. The total reaction volume was 1.5 mL, including 50 mM glucose, 50 mM NADP+, 50 mM PBS buffer (pH 7.5), and 20 μL of the enzyme solution. After reacting in a 30°C shaking water bath for 1 min, the absorbance was measured and recorded at 340 nm. Enzyme activity was calculated based on the linear rate of change of absorbance at 340 nm over time.

[0044] Enzyme activity is defined as the amount of enzyme required for glucose dehydrogenase (GDH) to catalyze the production of 1 μmol of NADPH per minute, which is 1 U.

[0045] Example 1: Preparation of D-amino acid oxidase mutant plasmid (1) Construction of wild-type plasmid and strain of D-amino acid oxidase Synthesized from Rhodotorula buergerianum ( Rhodosporidium toruloides The D-amino acid oxidase gene Daao (nucleotide sequence shown in SEQ ID NO.4) from *Rhodotorula glutinis* exhibits higher catalytic activity for various D-amino acids compared to traditional sources such as porcine kidney. It also demonstrates good thermostability, maintaining high activity within the 40℃~50℃ range and growing well at pH 7.5~9.0. The Daao gene was constructed into the pET-28a vector (enzyme restriction sites EcoRI and Hin). dIII The recombinant plasmid pET-28a-Daao was amplified using E. coli JM109, screened by colony PCR and Sanger sequencing, and finally obtained.

[0046] (2) Construction of D-amino acid oxidase mutant plasmid and strain Using the recombinant plasmid pET-28a-Daao prepared in step (1) as a template, primers containing mutation sites were designed (Table 1). Whole-plasmid PCR was performed on the pET-28a-Daao plasmid using the corresponding primers in Table 1 to amplify the recombinant plasmid pET-28a-Daao containing mutations A47C, A51S, Q335G, Q335P, Q335S, and Q335A. A47C pET-28a-Daao A51S pET-28a-Daao Q335G pET-28a-Daao Q335P pET-28a-Daao Q335S and pET-28a-Daao Q335A Among them, pET-28a-Daao A47C For example: The plasmid pET-28a-Daao was amplified by full plasmid PCR using primers A47C-F and A47C-R. The PCR product was purified and then... Dpn The bacteria were digested with enzyme I, and the digestion products were then transferred into E. coli JM109. After screening by colony PCR and Sanger sequencing, Daao bacteria were finally obtained. A47C Mutant recombinant plasmid pET-28a-Daao A47C .

[0047] Table 1 Primers

[0048] Example 2: Expression and purification of D-amino acid oxidase The recombinant plasmid pET-28a-Daao prepared in Example 1 and a series of mutant recombinant plasmids constructed in Example 1 were transformed into Escherichia coli BL21(DE3) to obtain recombinant strains. E.Coli BL21 / pETDuet-28a-Daao, E.Coli BL21 / pET-28a-Daao A47C , E.Coli BL21 / pET-28a-Daao A51S , E.Coli BL21 / pET-28a-Daao Q335G , E.Coli BL21 / pET-28a-Daao Q335P , E.Coli BL21 / pET-28a-Daao Q335S and E.Coli BL21 / pET-28a-Daao Q335A .

[0049] The recombinant strains were inoculated into 10 mL of LB liquid medium and activated at 37℃ and 200 rpm for 12 h. Then, they were transferred to 100 mL of TY fermentation medium at an inoculation rate of 1% (v / v) and cultured at 37℃ for another 2 h. Isopropyl-β-D-thiogalactoside (IPTG) was added to achieve a final concentration of 0.8 mM. The culture temperature was then adjusted to 25℃ and induced at 200 rpm for 20 h to induce the expression of D-amino acid oxidase.

[0050] After culture, the bacterial culture was collected, the cells were washed with phosphate buffer, centrifuged, and then the cells were collected and sonicated: 400 W, 1 s for 1 second, 3 s for 3 seconds, for 15 minutes. After disruption, the cells were centrifuged at 8,000 rpm for 20 minutes at 4°C to separate the cell wall disruption supernatant and the cell wall disruption precipitate, thus preparing the crude enzyme solutions of wild-type and mutant enzymes.

[0051] The crude wild-type enzyme was analyzed using SDS-PAGE, and the results are as follows: Figure 1 The molecular weight of the enzyme protein is approximately 40.1 kDa.

[0052] Example 3: Performance determination of D-amino acid oxidase This embodiment uses a colorimetric method to determine the enzyme activity of D-amino acid oxidase. Details are as follows: The total volume of the D-amino acid oxidase activity assay system was 3.6 mL. The specific sample addition procedure was as follows: 1.2 mL of PBS buffer (0.05 mM, pH 7.5) was added to the test tube, followed by 100 μL of 0.2 M D,L-glufosinate substrate, 100 μL of 400 U / mL catalase, and finally 20 μL of diluted enzyme solution. After thorough mixing, the sample dilution factor was recorded. The test tube was placed in a 30℃ constant temperature shaking water bath for reaction. After 15 min of reaction, 480 μL of 2,4-dinitrophenylhydrazine solution (2 mg / mL, prepared with 2 M hydrochloric acid) was immediately added. After mixing, the D-amino acid oxidase catalytic reaction was terminated. The system was then transferred to a 37℃ constant temperature water bath for incubation for 10 min. 1.7 mL of 3 M NaOH solution was added for colorimetric reaction. The concentration of the product was quantitatively detected by the addition reaction of 2,4-dinitrophenylhydrazine with aldehydes and ketones. After the reaction was completed, the absorbance of the sample was measured and recorded at a wavelength of 550 nm.

[0053] Enzyme activity definition: Under set temperature and pH conditions, the amount of enzyme required to catalyze the generation of 1 µmol PPO per minute (corresponding to the consumption of 1 µmol D-PPT) is defined as 1 enzyme activity unit (U).

[0054] (1) Optimal pH Phosphate buffer systems with pH values ​​of 6.5, 7.0, 7.5, 8.0, and 8.5 were prepared. The pH values ​​of each buffer system were adjusted using ammonia and phosphate. The enzyme activity of wild-type enzymes was then measured in different buffer systems.

[0055] (2) Determination of optimal temperature The enzyme activity of wild-type enzymes was determined under gradient temperature conditions of 25℃, 30℃, 35℃ and 40℃.

[0056] The results showed that the wild-type enzyme exhibited the highest catalytic activity in a phosphate buffer environment at 30℃ and pH 8.0. Figure 2 ).

[0057] Using the same method, the optimal pH and optimal temperature of the mutant enzyme were determined. The results showed that the optimal temperature for both the wild-type and mutant enzymes was 30℃ and the optimal pH was 8.0, before and after the mutation.

[0058] Example 4: Determination of D-Glufosinate Conversion Capacity This embodiment uses HPLC to determine the enzyme activity of the D-amino acid oxidase mutant. Details are as follows: Using the same method as in Example 2, the fermentation broth expressing the D-amino acid oxidase mutant was centrifuged to collect the cells, resuspended in pH 8.0 phosphate buffer, and diluted to OD. 600 =40, and then crushed to obtain crude enzyme solution.

[0059] The total reaction system for the D-amino acid oxidase mutant enzyme activity assay was 10 mL. The crude enzyme solution was preheated in a shaker at 30℃ and 200 rpm. Then, D,L-glufosinate-ammonium (30 g / L) and catalase (4 U / mL) were rapidly added. The reaction was carried out at 30℃ and 200 rpm for 3 h. A 1 mL sample was taken, and 10 μL of 6 M HCl was immediately added and thoroughly mixed to terminate the reaction. The concentration of PPO in the reaction solution was subsequently determined by HPLC.

[0060] The results are as follows Figure 3 As shown, Daao A51S The mutant enzyme activity was 79.22% lower than that of the wild type. Q335P The mutant enzyme activity was 95.87% lower than that of the wild type. A47C The mutant enzyme activity was increased by 3.59% compared to the wild type. Q335G The mutant enzyme activity was increased by 20.7% compared to the wild type, reaching 140 U. Q335S The mutant enzyme activity was increased by 2.82% compared to the wild type. Q335AThe mutant enzyme activity was 12.85% higher than the wild type. This indicates that the D-amino acid oxidase Daao with enhanced activity was successfully screened through mutant site design. Q335G .

[0061] Example 5: Conversion of Escherichia coli PPO-producing bacteria in a 5 L bioreactor 1. Preparation of crude enzyme solution Recombinant bacteria E.Coli BL21 / pET-28a-Daao Q335G After inoculating into 10 mL of LB liquid medium and culturing at 37°C and 200 rpm for 12 h, the inoculum was transferred to 100 mL of TY fermentation medium at a 1% (v / v) inoculation rate and cultured at 37°C and 200 rpm for 12 h to obtain the seed culture. The seed culture was then transferred to a 5 L bioreactor containing 1.9 L of TY fermentation medium at a 5% (v / v) inoculation rate. The pH was maintained at 7.2 using 50% NH3·H2O (v / v), and the dissolved oxygen level was maintained at approximately 30% by adjusting the stirring speed and aeration rate. After culturing at 37°C for 2 h, fed medium was added at a flow rate of 36 mL / h, and culturing continued for another 2 h. Then, IPTG was added to a final concentration of 0.5 mM, and the temperature was lowered to 25°C for induction for 20 h. When the OD of cells in the bioreactor... 600 Stop the bioreactor when the culture reaches 80%.

[0062] After culture, collect 0.5 L of bacterial culture, wash cells with phosphate buffer, centrifuge, collect cells, and sonicate: 400 W for 1 s, pause for 3 s, for 15 min. After lysis, centrifuge at 4℃, 8,000 rpm for 20 min, collect the supernatant, and obtain the mutant enzyme Daao. Q335G Crude enzyme solution.

[0063] 2. Enzymatic catalysis of racemic D-glufosinate The mutant enzyme Daao prepared in step 1 Q335G The crude enzyme solution was used entirely for the catalytic reaction: the mutant enzyme Daao from step 1 was diluted with phosphate buffer at pH 8.0. Q335G The crude enzyme solution was diluted to 1 L and added to a 5 L bioreactor. Subsequently, the reactor was preheated at 30°C, 200 rpm, and an aeration rate of 10 NL / min. After stabilization, the catalytic reaction was initiated. Specifically, 60 g of D,L-glufosinate was added at 0 h and 6 h of the catalytic reaction, respectively.

[0064] The results are as follows Figure 4As shown, at 6 h, the substrate added at 0 h reacted almost completely. After adding 60 g of D,L-glufosinate again, the concentration of D-glufosinate decreased rapidly within 6-14 h. At 14.5 h, the concentration of D-glufosinate was 3.2 g / L and the concentration of PPO was 51 g / L. At 18 h, no D-glufosinate was detected in the sample diluted 2000 times, and the concentration of PPO was 54 g / L, with a conversion rate >99%.

[0065] Example 6: Preparation of L-Glufosinate by Multi-Enzyme Cascade 1. Preparation of crude glutamate dehydrogenase solution and crude glucose dehydrogenase solution (1) Construction of plasmid pMA5-GluDH-GDH carrying glutamate dehydrogenase and glucose dehydrogenase and recombinant strain BBS2 Synthesized from Pseudomonas montelukastii ( Pseudomonas monteilii Glutamate dehydrogenase gene gludh (Amino acid sequence as shown in SEQ ID NO.5, nucleotide sequence as shown in SEQ ID NO.6) and derived from Siberian microbacterium ( Exiguobacterium sibiricum glucose dehydrogenase gene gdh (Amino acid sequence as shown in SEQ ID NO.7, nucleotide sequence as shown in SEQ ID NO.8), the gene gludh and gdh The recombinant plasmid pET-28a was constructed into the pET-28a vector (with EcoRI and HindIII restriction sites). Genes were linked together using RBS (gtaagagagg) and a spacer (aatgtacacGTAAAAAAGGAGGAGCGTT). The plasmid was amplified using E. coli JM109, and screened by colony PCR and Sanger sequencing to obtain the final recombinant plasmid pET-28a. -gludh - gdh .

[0066] The recombinant plasmid pET-28a -gludh - gdh Transformed into Escherichia coli BL21(DE3), recombinant strain BBS2 was obtained. E. coli BL21(DE3) / pET-28a- gludh - gdh ).

[0067] Glutamate dehydrogenase gene gludh The amino acid sequence is shown in SEQ ID NO.5: MIESVDNFLARLQQRDPGQPEFHQAVEEVLRTLWPFLEANPHYLQSGILERMVEPERAVLFRVSWVDDQGKVQVNRGYRIQMSSAIGPYKGGLRFHPSVNLSVLKFLAFEQVFKNSLTSLPMGGGKGGSDFDPKGKSDAEVMRFCQAFMSELYRHIGADCDVPAGDIGVGAREIGFMFGQYKRLANQFTSVLTGKGMTYGGSLIRPEATGYGCVYFAEEMLKRQDKRIDGCRVAISGSGNVAQYAARKVMDLGGKVISLSDSEGTLYAEAGLTDAQWDAVMELKNVKRGRISELAGQFGLEFRKGQTPWSLACDIALPCATQNELGAEDARTLLRNGCICVAEGANMPTTLEAVDIFLDAGILYAPGKASNAGGSAVSGLEMSQNAMRLLWTAGEVDSKLHNIMQSIHHACVHYGEEADGRINYVKGANIAGFVKVADAMLAQGVV Glutamate dehydrogenase gene gludh has the nucleotide sequence shown in SEQ ID NO. 6: glucose dehydrogenase gene gdh The amino acid sequence is shown in SEQ ID NO.7: MYNSLKGKVAIVTGGSMGIGEAIIRRYAEEGMRVVINYRSHPEEAKKIAEDIKQAGGEALTVQGDVSKEEDMINLVKQTVDHFGQLDVFVNNAGVEMPSPSHEMSLEDWQKVIDVNLTGAFLGAREALKY FVEHNVKGNIINMSSVHEIIPWPTFVHYAASKGGVKLMTQTLAMEYAPKGIRINAIGPGAINTPINAEKFEDPKQRADVESMIPMGNIGKPEEISAVAAWLASDEASYVTGITLFADGGMTLYPSFQAGRG glucose dehydrogenase gene gdh The nucleotide sequence is shown in SEQ ID NO.8: ATGTATAATTCACTAAAGGGACGGGTAGCTATCGTGACTGGCGGTAGCATGGGTATCGGCGAAGCGATCATCCGTCGTTACGCTGAAGAGGGTATGCGCGTGGTGATCAACTACCGCAGCCATCCGGAGGAGGCTAAAAAAATTGCTGAAGATATTAAACAAGCGGGTGGCGAAGCGCTCACGGTTCAGGGTGATGTGAGCAAAGAAGAGGACATGATTAACTTGGTTAAGCAAACCGTCGATCATTTCGGTCAGCTGGATGTTTTTGTCAATAACGCAGGCGTGGAGATGCCGTCCCCGAGCCACGAGATGTCTCTGGAAGACTGGCAGAAAGTTATTGACGTTAATTTGACGGGGGCGTTTCTGGGTGCGCGTGAAGCCCTGAAGTACTTCGTCGAGCACAACGTCAAGGGCAATATCATCAACATGTCCAGCGTTCACGAGATTATCCCGTGGCCGACCTTTGTGCATTATGCGGCTTCGAAGGGTGGTGTTAAGCTGATGACCCAGACCCTGGCAATGGAATATGCGCCAAAGGGCATCCGCATTAATGCGATTGGCCCTGGTGCCATCAACACCCCGATTAACGCCGAAAAATTCGAGGACCCGAAGCAGCGTGCGGACGTAGAGAGCATGATCCCGATGGGCAACATTGGTAAACCGGAAGAGATCAGCGCAGTTGCAGCGTGGCGGGCGTCTGATGAAGCTTCCTACGTGACCGGTATTACCTTGTTTGCCGACGGCGGCATGACCCTGTATCCGTCGTTCCAAGCGGGCCGTGGTTAA The ligated gludh - gdh gene sequence (SEQ ID NO.9) is as follows: (2) Expression of glutamate dehydrogenase and glucose dehydrogenase The recombinant strain BBS2 from step (1) was inoculated into 10 mL of LB liquid medium and cultured at 37°C and 200 r / min for 12 h. Then, it was transferred to 50 mL of LB liquid medium at a 1% (v / v) inoculation rate and cultured for 2 h. Finally, 0.5 mM IPTG was added and the temperature was lowered to 25°C and cultured at 200 r / min until the OD was reached. 600 =40, collect bacterial culture. Wash cells with PBS solution, centrifuge and collect cells, sonicate in an ice-water bath (400 W, 1s s s s s s s s s s s s s s s s s s 30 min), centrifuge at 4℃, 8000 rpm for 20 min, separate the cell wall disruption supernatant and cell wall disruption precipitate, collect the supernatant as crude enzyme solution, obtain crude glutamate dehydrogenase and crude glucose dehydrogenase enzyme solutions, with enzyme activities of 463.32 U and 809.78 U, respectively.

[0068] The crude enzymes were analyzed using SDS-PAGE. The molecular weight of glutamate dehydrogenase protein was approximately 48.5 kDa, and the molecular weight of glucose dehydrogenase protein was approximately 28.3 kDa.

[0069] 2. Mutant enzyme Daao Q335G Preparation of crude enzyme solution Recombinant bacteria E.Coli BL21 / pET-28a-Daao Q335G The inoculum was inoculated into 10 mL of LB liquid medium and cultured at 37°C and 200 rpm for 12 h. Then, it was transferred to 100 mL of TY fermentation medium at a 1% (v / v) inoculation rate and cultured at 37°C and 200 rpm for 12 h to obtain the seed culture. The seed culture was then transferred to a 5 L bioreactor containing 1.9 L of TY fermentation medium at a 5% (v / v) inoculation rate. 50% NH4+ was used. 3` The pH was maintained at 7.2 with H2O (v / v), and the dissolved oxygen level was maintained at approximately 30% by adjusting the stirring speed and aeration rate. After culturing at 37°C for 2 h, fed culture medium was added at a flow rate of 36 mL / h, and culturing continued for another 2 h. Then, IPTG was added to a final concentration of 0.5 mM, and the temperature was lowered to 25°C for induction for 20 h. When the OD of cells in the bioreactor... 600 Stop the bioreactor when the culture reaches 80%.

[0070] After culture, collect 0.5 L of bacterial culture, wash cells with phosphate buffer, centrifuge, collect cells, and sonicate: 400 W for 1 s, pause for 3 s, for 15 min. After lysis, centrifuge at 4℃, 8000 rpm for 20 min, collect the supernatant, and obtain the mutant enzyme Daao. Q335G Crude enzyme solution.

[0071] 3. Preparation of L-PPT by multi-enzyme cascade reaction (1) Enzymatic preparation of PPO The mutant enzyme Daao prepared in step 2 Q335G crude enzyme solution (initial OD) 600 The cell quantity was 40. For the catalytic reaction: the mutant enzyme Daao from step 2 was diluted with phosphate buffer at pH 8.0. Q335G The crude enzyme solution was added to a 1 L volume and then to a 5 L bioreactor. The reaction system was then preheated at 30 °C, 200 rpm, and an aeration rate of 10 NL / min. After stabilization, the catalytic reaction was carried out. Specifically, 60 g of D,L-glufosinate was added at 0 h and 6 h of the catalytic reaction to prepare a reaction solution containing PPO.

[0072] (2) Enzymatic preparation of L-PPT The crude glutamate dehydrogenase solution prepared in step 1 was mixed with the crude glucose dehydrogenase solution (initial OD). 600 The cell quantity is 40) All of them are used for catalytic reaction: The reaction system includes 1 L of PPO-containing reaction solution prepared in step (1), 1 L of crude glutamate dehydrogenase and crude glucose dehydrogenase prepared in step 1, and NADP + 5 mg / L ammonium sulfate, 40 g ammonium sulfate and 20 g glucose were reacted at 30℃ and pH 8.0 with stirring at 200 rpm; 20 g glucose and 30 g glucose were added at 2 h and 4 h respectively.

[0073] like Figure 5 As shown, after 10 h of reaction, the sample was analyzed by HPLC, and the final L-PPT concentration was 115.5 g / L, the conversion rate was 92.5%, and ee>99%.

[0074] Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Anyone skilled in the art can make various modifications and alterations without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be determined by the claims.

Claims

1. A D-amino acid oxidase mutant, characterized in that, The D-amino acid oxidase mutant is based on the D-amino acid oxidase shown in SEQ ID NO.1, with glutamine at position 335 mutated to glycine.

2. A gene encoding the D-amino acid oxidase mutant of claim 1, or a recombinant vector carrying the gene.

3. A cell expressing the mutant of claim 1, or a recombinant cell carrying the gene or recombinant vector of claim 2; Preferably, the recombinant cells are bacteria or fungi as host cells; more preferably, the bacteria are selected from Escherichia coli, Bacillus subtilis or Corynebacterium glutamicum, and the fungi are yeast.

4. A recombinant enzyme catalyst comprising the D-amino acid oxidase mutant of claim 1, wherein It can be any of the following forms: (1) Culturing the recombinant cells of claim 3, and isolating cells containing the mutant; (2) Culturing the recombinant cells of claim 3, separating and lysing the cells to obtain a cell lysate containing the mutant; (3) The freeze-dried enzyme powder obtained by freeze-drying the cell lysate.

5. A method for improving the catalytic performance of a D-amino acid oxidase, characterized by, The D-amino acid oxidase mutant is based on the D-amino acid oxidase shown in SEQ ID NO.1, with glutamine at position 335 mutated to glycine.

6. A genetically engineered bacterium, characterized by, The genetically engineered bacteria expressed the D-amino acid oxidase mutant of claim 1; Preferably, the genetically engineered bacteria also express at least one coenzyme associated with the production of 2-oxo-4-[(hydroxy)(-methyl)phosphine]butyric acid (PPO); More preferably, the coenzyme includes catalase; Preferably, the host of the genetically engineered bacteria is Escherichia coli BL21(DE3).

7. A method of resolving racemic D,L-glufosinate, characterized in that, Using D,L-glufosinate as a substrate, and employing the recombinant cells of claim 3, the recombinase catalyst of claim 4, or the genetically engineered bacteria of claim 6 as catalysts, racemic D,L-glufosinate is cleaved to generate the intermediate PPO.

8. The method of claim 7, wherein, The catalytic system also includes catalase.

9. The method of claim 7, wherein, The catalytic temperature is 25~40℃, and the pH is 7~8.

10. The use of the mutant of claim 1, the gene or recombinant vector of claim 2, the recombinant cell of claim 3, the recombinase catalyst of claim 4, the genetically engineered bacteria of claim 6, or the method of claim 7 or 8 in any of the following: (1) Preparation of L-glufosinate; (2) Preparation of intermediate PPO.